RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy (STREAM)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ticagrelor (Primary)
Indications Acute coronary syndromes; Myocardial infarction; Unstable angina pectoris
Focus Therapeutic Use
Acronyms STREAM
Sponsors AstraZeneca

Most Recent Events

16 Aug 2018 Status changed from active, no longer recruiting to completed.
20 Feb 2017 Planned End Date changed from 1 Jun 2018 to 1 Jul 2018.
20 Feb 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jul 2018.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight